JP2010535026A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010535026A5 JP2010535026A5 JP2010518815A JP2010518815A JP2010535026A5 JP 2010535026 A5 JP2010535026 A5 JP 2010535026A5 JP 2010518815 A JP2010518815 A JP 2010518815A JP 2010518815 A JP2010518815 A JP 2010518815A JP 2010535026 A5 JP2010535026 A5 JP 2010535026A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- influenza
- peptide
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 32
- 229920001184 polypeptide Polymers 0.000 claims 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims 16
- 101710154606 Hemagglutinin Proteins 0.000 claims 15
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 15
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 15
- 101710176177 Protein A56 Proteins 0.000 claims 15
- 239000000185 hemagglutinin Substances 0.000 claims 15
- 102000011931 Nucleoproteins Human genes 0.000 claims 11
- 108010061100 Nucleoproteins Proteins 0.000 claims 11
- 206010022000 influenza Diseases 0.000 claims 11
- 241000712461 unidentified influenza virus Species 0.000 claims 7
- 125000000539 amino acid group Chemical group 0.000 claims 6
- 238000006116 polymerization reaction Methods 0.000 claims 4
- 229960005486 vaccine Drugs 0.000 claims 4
- 210000001744 T-lymphocyte Anatomy 0.000 claims 2
- 210000003719 b-lymphocyte Anatomy 0.000 claims 2
- 229920001400 block copolymer Polymers 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 125000006850 spacer group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95349807P | 2007-08-02 | 2007-08-02 | |
| US60/953,498 | 2007-08-02 | ||
| PCT/IL2008/001062 WO2009016639A2 (en) | 2007-08-02 | 2008-08-03 | Multimeric multiepitope influenza vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010535026A JP2010535026A (ja) | 2010-11-18 |
| JP2010535026A5 true JP2010535026A5 (enExample) | 2011-09-15 |
| JP5654345B2 JP5654345B2 (ja) | 2015-01-14 |
Family
ID=40305020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518815A Expired - Fee Related JP5654345B2 (ja) | 2007-08-02 | 2008-08-03 | 多量体マルチエピトープインフルエンザワクチン |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8747861B2 (enExample) |
| EP (1) | EP2173376B1 (enExample) |
| JP (1) | JP5654345B2 (enExample) |
| KR (1) | KR101580660B1 (enExample) |
| CN (1) | CN101795709B (enExample) |
| AU (1) | AU2008281384C1 (enExample) |
| BR (1) | BRPI0815008B8 (enExample) |
| CA (1) | CA2695399C (enExample) |
| DK (1) | DK2173376T3 (enExample) |
| EA (1) | EA017887B1 (enExample) |
| ES (1) | ES2539818T3 (enExample) |
| HR (1) | HRP20150479T1 (enExample) |
| HU (1) | HUE025149T2 (enExample) |
| MX (1) | MX2010001284A (enExample) |
| PL (1) | PL2173376T3 (enExample) |
| PT (1) | PT2173376E (enExample) |
| WO (1) | WO2009016639A2 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1841785A2 (en) | 2005-01-19 | 2007-10-10 | Vaxinnate Corporation | Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response |
| US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| CA2976814C (en) | 2007-08-27 | 2022-12-13 | Longhorn Vaccines & Diagnostics, Llc | Immunogenic compositions and methods for treating influenza |
| WO2009128952A2 (en) | 2008-04-18 | 2009-10-22 | Vaxinnate Corporation | Compositions of papillomavirus proteins and methods of use |
| WO2011067758A2 (en) | 2009-12-02 | 2011-06-09 | Protea Vaccine Technologies Ltd. | Immunogenic fragments and multimers from streptococcus pneumoniae proteins |
| WO2012026712A2 (ko) | 2010-08-23 | 2012-03-01 | 주식회사 강스템홀딩스 | Ｎｏｄ２의 아고니스트를 처리한 줄기세포 또는 그 배양물을 포함하는 면역질환 또는 염증질환의 예방 또는 치료용 약학조성물 |
| WO2012115715A2 (en) * | 2011-02-21 | 2012-08-30 | Vaxinnate Corporation | Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use |
| AU2011360572B2 (en) * | 2011-02-22 | 2017-03-02 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
| JP6113155B2 (ja) * | 2011-06-20 | 2017-04-12 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 計算で最適化した広い反応性を示すｈ１ｎ１インフルエンザの抗原 |
| WO2013037804A1 (en) * | 2011-09-12 | 2013-03-21 | Laboratorios Del Dr. Esteve, S.A. | Method for monitoring cytotoxic t lymphocyte (ctl) responses by a delayed-type hypersensitivity reaction using defined ctl viral epitopes |
| EP2806890A4 (en) * | 2012-01-26 | 2015-09-02 | Longhorn Vaccines & Diagnostics Llc | COMPOSITIONAL ANTIGEN SEQUENCES AND VACCINES |
| HK1203983A1 (en) * | 2012-04-02 | 2015-11-06 | Folia Biotech Inc. | Recombinant papaya mosaic virus coat proteins and uses thereof in influenza vaccines |
| CN103055311B (zh) * | 2012-12-28 | 2014-05-21 | 中山大学 | 一种传染性喉气管炎粘膜疫苗及其制备方法和应用 |
| CN109045294A (zh) * | 2013-01-10 | 2018-12-21 | 思齐乐 | 流感病毒免疫原性组合物及其应用 |
| CN106163553B (zh) * | 2014-04-03 | 2021-07-23 | 彼昂德瓦克斯医药有限公司 | 多聚体-多表位流感多肽的组合物及其产生 |
| EP3411712B1 (en) * | 2016-02-03 | 2025-11-19 | CG Discovery, Inc. | Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites |
| JP2019064924A (ja) * | 2016-02-24 | 2019-04-25 | Ａｇｃ株式会社 | インフルエンザワクチン |
| BR112019013402A2 (pt) | 2016-12-28 | 2020-03-03 | Invvax, Inc. | Vacinas de influenza |
| WO2019061297A1 (zh) * | 2017-09-29 | 2019-04-04 | 苏州工业园区唯可达生物科技有限公司 | 一种cd4辅助性t细胞表位融合肽及其疫苗 |
| EP3730620A4 (en) * | 2017-12-21 | 2022-01-05 | Green Biomed, Inc. | CROSS-IMMUNIZING ANTIGEN VACCINE AND METHOD OF ITS MANUFACTURING |
| CN112218877B (zh) | 2018-08-27 | 2025-07-25 | 瑞泽恩制药公司 | 拉曼光谱在下游纯化中的应用 |
| CN111315407B (zh) * | 2018-09-11 | 2023-05-02 | 上海市公共卫生临床中心 | 一种广谱抗流感疫苗免疫原及其应用 |
| WO2020257317A1 (en) * | 2019-06-18 | 2020-12-24 | Citranvi Biosciences, Llc | Rationally engineered carrier proteins for vaccines |
| AU2021221139A1 (en) * | 2020-02-14 | 2022-09-01 | University Of Washington | Polypeptides, compositions, and their use to treat or limit development of an infection |
| US11149286B1 (en) | 2020-08-17 | 2021-10-19 | Mayo Foundation For Medical Education And Research | Adenovirus vectors and methods for using adenovirus vectors |
| WO2022061297A1 (en) * | 2020-09-21 | 2022-03-24 | Brown Kathlynn C | Targeted antigen delivery system and uses thereof |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4767842A (en) | 1973-05-07 | 1988-08-30 | The Ohio State University | Antigenic modification of polypeptides |
| IL61904A (en) | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
| US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| US4866034A (en) | 1982-05-26 | 1989-09-12 | Ribi Immunochem Research Inc. | Refined detoxified endotoxin |
| US4643992A (en) | 1982-11-09 | 1987-02-17 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
| US4539205A (en) | 1982-11-09 | 1985-09-03 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
| US4987237A (en) | 1983-08-26 | 1991-01-22 | Ribi Immunochem Research, Inc. | Derivatives of monophosphoryl lipid A |
| US5093318A (en) | 1983-11-01 | 1992-03-03 | Scripps Clinic And Research Foundation | Immunostimulating guanosine derivatives and their pharmaceutical compositions |
| US5011828A (en) | 1985-11-15 | 1991-04-30 | Michael Goodman | Immunostimulating guanine derivatives, compositions and methods |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US6130082A (en) | 1988-05-05 | 2000-10-10 | American Cyanamid Company | Recombinant flagellin vaccines |
| JPH0832638B2 (ja) | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
| US5709879A (en) | 1990-06-29 | 1998-01-20 | Chiron Corporation | Vaccine compositions containing liposomes |
| US5837268A (en) * | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
| GB9201139D0 (en) | 1992-01-20 | 1992-03-11 | Connaught Lab | Synthetic peptides for a rubella vaccine |
| IL101639A0 (en) | 1992-04-17 | 1992-12-30 | Yeda Res & Dev | Recombinant influenza vaccines |
| NZ253137A (en) | 1992-06-25 | 1996-08-27 | Smithkline Beecham Biolog | Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a. |
| WO1994006421A1 (en) | 1992-09-16 | 1994-03-31 | The University Of Tennessee Research Corporation | Recombinant multivalent m protein vaccine |
| US5683695A (en) | 1993-02-10 | 1997-11-04 | United Biomedical, Inc. | Production of recombinant proteins containing multiple antigenic determinants linked by flexible hinge domains |
| EP0689454B2 (en) | 1993-03-23 | 2005-02-23 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| DE69535905D1 (de) | 1994-07-15 | 2009-02-26 | Coley Pharm Group Inc | Immunomodulatorische Oligonukleotide |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| CO4600681A1 (es) | 1996-02-24 | 1998-05-08 | Boehringer Ingelheim Pharma | Composicion farmaceutica para la modulacion inmunitaria |
| US6303347B1 (en) | 1997-05-08 | 2001-10-16 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| US7063967B2 (en) | 1997-05-08 | 2006-06-20 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| US6355257B1 (en) | 1997-05-08 | 2002-03-12 | Corixa Corporation | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| US6080725A (en) | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
| BR9809149A (pt) | 1997-05-20 | 2000-08-01 | Galenica Pharmaceuticals Inc | Análogos de triterpeno saponina dotados de adjuvante e atividade imonoestimulatória |
| DE69832706T2 (de) | 1997-08-05 | 2006-08-10 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. | Immunschützendes influenzaantigen und dessen verwendung zur impfung |
| CA2302554C (en) | 1997-09-05 | 2007-04-10 | Smithkline Beecham Biologicals S.A. | Oil in water emulsions containing saponins |
| GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
| CA2314934C (en) | 1997-12-16 | 2006-08-29 | Chiron Corporation | Use of microparticles combined with submicron oil-in-water emulsions |
| HUP0101619A3 (en) | 1998-04-09 | 2003-11-28 | Smithkline Beecham Biolog | Adjuvant compositions |
| GB9807805D0 (en) | 1998-04-09 | 1998-06-10 | Smithkline Beecham Biolog | Vaccine |
| DK1075276T3 (da) | 1998-05-07 | 2008-02-11 | Corixa Corp | Adjuvanssammensætning og fremgangsmåder til dens anvendelse |
| CA2337754C (en) | 1998-08-21 | 2011-05-24 | Altaf A. Lal | Recombinant multivalent malarial vaccine against plasmodium falciparum |
| IL127331A0 (en) | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
| CA2377525A1 (en) | 1999-07-19 | 2001-03-29 | Epimmune Inc. | Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
| EP1225907A4 (en) | 1999-10-05 | 2005-06-22 | Epimmune Inc | INDUCING CELLULAR IMMUNE RESPONSES TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| US6843781B2 (en) | 1999-10-14 | 2005-01-18 | Becton, Dickinson And Company | Intradermal needle |
| BRPI0111830B8 (pt) | 2000-06-23 | 2021-05-25 | American Cyanamid Co | método de produção de partículas semelhantes ao vírus da influenza (vlps), vlps da influenza, vlps quiméricas, composições imunogênica e farmacêutica, e, usos de vlps da influenza e de vlps quiméricas |
| WO2004003145A2 (en) | 2002-06-28 | 2004-01-08 | Nastech Pharmaceutical Company Inc. | Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| RU2005131016A (ru) | 2003-03-07 | 2006-06-10 | Мерк энд Ко., Инк. (US) | Вакцина вируса гриппа |
| US7108679B2 (en) | 2004-03-11 | 2006-09-19 | Becton, Dickinson And Company | Intradermal syringe and needle assembly |
| US7794731B2 (en) * | 2004-12-16 | 2010-09-14 | Wake Forest University Health Sciences | Use of flagellin in the immunotherapy of Yersinia pestis |
| JP2008524261A (ja) | 2004-12-21 | 2008-07-10 | バクシネート コーポレーション | インフルエンザウイルスタンパク質の組成物およびその使用方法 |
| EP1841785A2 (en) | 2005-01-19 | 2007-10-10 | Vaxinnate Corporation | Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response |
| CA2610667A1 (en) * | 2005-06-01 | 2006-12-07 | Variation Biotechnologies Inc. | Peptide-based influenza vaccine formulation |
| US7260958B2 (en) | 2005-09-14 | 2007-08-28 | National Taipei University Technology | Electrohydrodynamic condenser device |
| US20100158943A1 (en) | 2005-11-04 | 2010-06-24 | Novartis Vaccines And Diagnostics Srl | Administration routes for priming/boosting with influenza vaccines |
| ES2385842T3 (es) | 2005-12-06 | 2012-08-01 | Yeda Research And Development Co., Ltd. | Vacuna mejorada contra la gripe |
| GB0613977D0 (en) | 2006-02-07 | 2006-08-23 | Peptcell Ltd | Peptide sequences and compositions |
| EP2069376A4 (en) * | 2006-07-21 | 2013-10-16 | Pharmexa Inc | INDUCTION OF CELLULAR IMMUNE RESPONSES TO INFLUENZA VIRUS BY COMPOSITIONS OF PEPTIDES AND NUCLEIC ACIDS |
| US9452209B2 (en) | 2007-04-20 | 2016-09-27 | Glaxosmithkline Biologicals Sa | Influenza vaccine |
| US20090196915A1 (en) | 2007-08-21 | 2009-08-06 | Gary Van Nest | Composition and methods of making and using influenza proteins |
-
2008
- 2008-08-03 MX MX2010001284A patent/MX2010001284A/es active IP Right Grant
- 2008-08-03 WO PCT/IL2008/001062 patent/WO2009016639A2/en not_active Ceased
- 2008-08-03 AU AU2008281384A patent/AU2008281384C1/en not_active Ceased
- 2008-08-03 US US12/671,617 patent/US8747861B2/en active Active
- 2008-08-03 HU HUE08789738A patent/HUE025149T2/hu unknown
- 2008-08-03 HR HRP20150479TT patent/HRP20150479T1/hr unknown
- 2008-08-03 EA EA201070219A patent/EA017887B1/ru not_active IP Right Cessation
- 2008-08-03 EP EP08789738.5A patent/EP2173376B1/en active Active
- 2008-08-03 CN CN2008801015810A patent/CN101795709B/zh not_active Expired - Fee Related
- 2008-08-03 DK DK08789738.5T patent/DK2173376T3/en active
- 2008-08-03 CA CA2695399A patent/CA2695399C/en not_active Expired - Fee Related
- 2008-08-03 ES ES08789738.5T patent/ES2539818T3/es active Active
- 2008-08-03 PL PL08789738T patent/PL2173376T3/pl unknown
- 2008-08-03 KR KR1020107003351A patent/KR101580660B1/ko not_active Expired - Fee Related
- 2008-08-03 PT PT87897385T patent/PT2173376E/pt unknown
- 2008-08-03 BR BRPI0815008A patent/BRPI0815008B8/pt not_active IP Right Cessation
- 2008-08-03 JP JP2010518815A patent/JP5654345B2/ja not_active Expired - Fee Related
-
2014
- 2014-04-28 US US14/263,359 patent/US9353159B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010535026A5 (enExample) | ||
| US20240075125A1 (en) | Expression systems | |
| JP6957580B2 (ja) | 新規多価ナノ粒子に基づくワクチン | |
| HRP20150479T1 (hr) | Multimeriäśna multiepitopska cjepiva protiv influence | |
| Kim et al. | Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection | |
| KR101736897B1 (ko) | 인플루엔자 항원 수송 벡터 및 구조물 | |
| JP2014507146A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| JP2012511914A5 (enExample) | ||
| JP2015506705A5 (enExample) | ||
| US11160858B2 (en) | Live recombinant measles-M2 virus—its use in eliciting immunity against influenza viruses | |
| RU2018113521A (ru) | Рекомбинантный полипептид гемагглютинин (ha) вируса гриппа для вызова иммунного ответа в отношении вирусов гриппа h2n2 или b | |
| WO2006037038B1 (en) | Optimized vaccines to provide protection against ebola and other viruses | |
| JP2014527526A5 (enExample) | ||
| JP7403733B2 (ja) | インフルエンザｈａスプリットワクチンの製造方法 | |
| Park et al. | Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge | |
| CN103732249A (zh) | 含有经修饰腺病毒载体的流感疫苗 | |
| Hong et al. | Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development | |
| Wang et al. | Improving cross-protection against influenza virus using recombinant vaccinia vaccine expressing NP and M2 ectodomain tandem repeats | |
| Zhao et al. | An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus | |
| CN107344969A (zh) | 一种纳米流感疫苗及构建方法和应用 | |
| RU2013102929A (ru) | Пан-лиссавирусные вакцины против бешенства | |
| JP2019534242A5 (enExample) | ||
| WO2020245722A1 (en) | Live attenuated universal influenza virus vaccines, methods and uses thereof | |
| JP2014530610A5 (enExample) |